LEXARIA BIOSCIENCE Buy Hold or Sell Recommendation

LXRP -- USA Stock  

USD 0.40  0.0089  2.18%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding LEXARIA BIOSCIENCE CORP is 'Strong Sell'. Macroaxis provides LEXARIA BIOSCIENCE buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LXRP positions. The advice algorithm takes into account all of LEXARIA BIOSCIENCE CORP available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from LXRP buy-and-hold prospective. Please see also LEXARIA BIOSCIENCE Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon LEXARIA BIOSCIENCE CORP has a mean deviation of 7.2, semi deviation of 0.0, standard deviation of 9.58, variance of 91.76, downside variance of 0.0 and semi variance of 0.0
We provide buy, hold, or sell recommendation to complement the last-minute expert consensus on LEXARIA BIOSCIENCE CORP. Our dynamic recommendation engine harnesses multi - dimensional algorithm to analyze the entity potential to grow using all technical and fundamental data available now. To make sure LEXARIA BIOSCIENCE CORP is not overpriced, please verify all LEXARIA BIOSCIENCE CORP fundamentals including its Current Ratio as well as the relationship between Market Capitalization and Z Score . As LEXARIA BIOSCIENCE CORP appears to be a penny stock we also strongly suggest to check its Price to Book numbers.

LEXARIA BIOSCIENCE Trading Alerts and Improvement Suggestions

LEXARIA BIOSCIENCE generates negative expected return over the last 30 days
LEXARIA BIOSCIENCE has high historical volatility and very poor performance
LEXARIA BIOSCIENCE has some characteristics of a very speculative penny stock
LEXARIA BIOSCIENCE has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 222.61 K. Net Loss for the year was (4.1 M) with profit before overhead, payroll, taxes, and interest of 192.53 K.
LEXARIA CORP currently holds about 1.35 M in cash with (3.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Latest headline from marketexclusive.com: LEXARIA BIOSCIENCE CORP. Files An 8-K Unregistered Sales of Equity Securities - Market Exclusive

LEXARIA BIOSCIENCE current analysts recommendations

Target Median Price1.77
Target Mean Price1.77
Recommendation Mean1.50
Target High Price2.35
Number Of Analyst Opinions2
Target Low Price1.20

LEXARIA BIOSCIENCE Returns Distribution Density

Mean Return0.25Value At Risk15.96
Potential Upside15.48Standard Deviation9.58
 Return Density 


Alpha over DOW
Beta against DOW=1.36
Overall volatility
Information ratio =0.03


LEXARIA BIOSCIENCE CORP is displaying above average volatility of 9.58 over selected time horizon. Investors should scrutinize LEXARIA BIOSCIENCE CORP independently to make sure intended market timing strategies are aligned with expectations about LEXARIA BIOSCIENCE volatility. LEXARIA BIOSCIENCE CORP is a potential penny stock. Although LEXARIA BIOSCIENCE may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in LEXARIA BIOSCIENCE CORP. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare LEXARIA BIOSCIENCE to competition


FundamentalsLEXARIA BIOSCIENCEPeer Average
Return On Equity(170.46) (0.31) 
Return On Asset(97.68) (0.14) 
Current Valuation34.21 M16.62 B
Shares Outstanding78.79 M571.82 M
Shares Owned by Insiders19.98 10.09 
Shares Owned by Institutions2.11 39.21 
Price to Earning(13.00) 28.72 
Price to Book14.58 9.51 
Price to Sales154.79 11.42 
Revenue222.61 K9.43 B
Gross Profit192.53 K27.38 B
EBITDA(3.93 M)3.9 B
Net Income(4.1 M)570.98 M
Cash and Equivalents1.35 M2.7 B
Cash per Share0.02 5.01 
Debt to Equity1.40 48.70 
Current Ratio9.86 2.16 
Book Value Per Share0.03 1.93 K
Cash Flow from Operations(3.01 M)971.22 M
Earnings Per Share(0.05) 3.12 
Number of Employees818.84 K
Market Capitalization34.46 M19.03 B
Total Asset331 K29.47 B
Retained Earnings(10.99 M)9.33 B
Working Capital(53 K)1.48 B
Current Asset279 K9.34 B
Current Liabilities332 K7.9 B
Z Score-82.58.72
   Lexaria Bioscience exotic insider transaction detected [view details]


Search macroaxis.com